[Untitled]

Autor: Pospelova Tv, Nikolai D. Aksenov, Valery A. Pospelov, A. I. Brichkina, Bulavin Dv, Tararova Nd

Publikováno v: Molecular Biology. 36:44-49

Introduction of the E1A early region of the human adenovirus type 5 impairs the ability of mammalian cells to stop in the cell cycle at G1/S after damage. Two-parameter fluorescence cell sorting with iododeoxyuridine revealed the radiation-induced G1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a07ba1875e7689b9bbd5c9d971d55ceb
https://doi.org/10.1023/a:1014242322335

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase.

Autor: Ragavan VN; Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany.; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre, Bedford Park, Adelaide, SA, Australia., Nair PC; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre, Bedford Park, Adelaide, SA, Australia.; Flinders Health and Medical Research Institute (FHMRI), College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.; Cancer Program, South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, Adelaide, SA, Australia.; Discipline of Medicine, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Jarzebska N; Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany., Angom RS; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA., Ruta L; Department of Pharmaceutical Sciences, University of Perugia, via del Liceo 1, Perugia, Italy., Bianconi E; Department of Pharmaceutical Sciences, University of Perugia, via del Liceo 1, Perugia, Italy., Grottelli S; Department of Medicine and Surgery, University of Perugia, P.le L. Sevari 1, Perugia, Italy., Tararova ND; DAPCEL, Inc., Cleveland, OH, USA., Ryazanskiy D; DAPCEL, Inc., Cleveland, OH, USA., Lentz SR; Department of Internal Medicine, The University of Iowa Carver College of Medicine, Iowa City, IA, USA., Tommasi S; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre, Bedford Park, Adelaide, SA, Australia., Martens-Lobenhoffer J; Institute of Clinical Pharmacology, Otto von Guericke University, Magdeburg, Germany., Suzuki-Yamamoto T; Department of Nutritional Science, Faculty of Health and Welfare Science, Okayama Prefectural University, Okayama, Japan., Kimoto M; Department of Nutritional Science, Faculty of Health and Welfare Science, Okayama Prefectural University, Okayama, Japan., Rubets E; Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany., Chau S; Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, NY, USA., Chen Y; Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, USA., Hu X; Institute of Molecular Medicine, Beijing University, Beijing, China., Bernhardt N; Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Spieth PM; Department of Anesthesiology and Critical Care Medicine, University Hospital Dresden, Technische Universität Dresden, Dresden, Germany., Weiss N; Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany., Bornstein SR; Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany.; School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK., Mukhopadhyay D; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA., Bode-Böger SM; Institute of Clinical Pharmacology, Otto von Guericke University, Magdeburg, Germany., Maas R; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; FAU New - Research Center for New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Wang Y; Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, NY, USA., Macchiarulo A; Department of Pharmaceutical Sciences, University of Perugia, via del Liceo 1, Perugia, Italy., Mangoni AA; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre, Bedford Park, Adelaide, SA, Australia., Cellini B; Department of Medicine and Surgery, University of Perugia, P.le L. Sevari 1, Perugia, Italy., Rodionov RN; Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany. Roman.Rodionov@uniklinikum-dresden.de.; College of Medicine and Public Health, Flinders University and Flinders Medical Center, Adelaide, SA, Australia. Roman.Rodionov@uniklinikum-dresden.de.

Publikováno v: Nature communications [Nat Commun] 2023 Jun 09; Vol. 14 (1), pp. 3392. Date of Electronic Publication: 2023 Jun 09.

Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation.

Autor: Logunov DY; Gamaleya Research Institute for Epidemiology and Microbiology, Moscow, Russia., Scheblyakov DV, Zubkova OV, Shmarov MM, Rakovskaya IV, Gurova KV, Tararova ND, Burdelya LG, Naroditsky BS, Ginzburg AL, Gudkov AV

Publikováno v: Oncogene [Oncogene] 2008 Jul 31; Vol. 27 (33), pp. 4521-31. Date of Electronic Publication: 2008 Apr 14.